about
Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenic-transformed epithelial cellsFrom an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaIntracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction.Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice.A case of Bowen's disease and small-cell lung carcinoma: long-term consequences of chronic arsenic exposure in Chinese traditional medicine.The impact of diet and betel nut use on skin lesions associated with drinking-water arsenic in Pabna, Bangladesh.Role of endoplasmic reticulum stress in drug-induced toxicityAssociation of arsenic with adverse pregnancy outcomes/infant mortality: a systematic review and meta-analysisSubinhibitory arsenite concentrations lead to population dispersal in Thiomonas spRenal function is associated with indicators of arsenic methylation capacity in Bangladeshi adultsArsenic-mediated activation of the Nrf2-Keap1 antioxidant pathwayBioremediation and tolerance of humans to heavy metals through microbial processes: a potential role for probiotics?Progress and prospects of reactive oxygen species in metal carcinogenesisArsenic binding to proteinsIncorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead, and mercury: strategies and challengesApigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expressionArsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant responseArsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart studyRETRACTED: Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced CarcinogenesisCreatinine, diet, micronutrients, and arsenic methylation in West Bengal, IndiaEffects of arsenic exposure on DNA methylation and epigenetic gene regulationEvaluating the spatial distribution of quantitative risk and hazard level of arsenic exposure in groundwater, case study of Qorveh County, Kurdistan IranAssociation of Cardiometabolic Genes with Arsenic Metabolism Biomarkers in American Indian Communities: The Strong Heart Family Study (SHFS)Paralogous Regulators ArsR1 and ArsR2 of Pseudomonas putida KT2440 as a Basis for Arsenic Biosensor DevelopmentHeavy metal toxicity and the environmentPreliminary morphological and immunohistochemical changes in rat hippocampus following postnatal exposure to sodium arseniteDisruption of ptLPD1 or ptLPD2, genes that encode isoforms of the plastidial lipoamide dehydrogenase, confers arsenate hypersensitivity in ArabidopsisCombined administration of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in ratsQualitative and quantitative characterization of the arsenic-binding behaviour of sulfur-containing peptides and proteins by the coupling of reversed phase liquid chromatography to electrospray ionization mass spectrometry.Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.Energy cost of intracellular metal and metalloid detoxification in wild-type eukaryotic phytoplankton.Oncogenomic disruptions in arsenic-induced carcinogenesis.From phosphorous to arsenic: changing the classic paradigm for the structure of biomolecules.Effect of Vitamin E Supplementation on Hematological and Plasma Biochemical Parameters during Long Term Exposure of Arsenic in GoatsEnhancement of arsenic trioxide-mediated changes in human induced pluripotent stem cells (IPS)The effects of arsenic trioxide on DNA synthesis and genotoxicity in human colon cancer cellsDistinct signaling pathways respond to arsenite and reactive oxygen species in Schizosaccharomyces pombe.Arsenic and Chronic Kidney Disease: A Systematic ReviewArsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.Arsenic exposure, dermatological lesions, hypertension, and chromosomal abnormalities among people in a rural community of northwest Iran
P2860
Q23919675-24AE0BEF-01BF-446F-996C-F98FE0C1C0E6Q24605527-3901A3F6-0639-4E59-8325-E19E726B1F0BQ24813110-3CD7E0ED-EE4D-4D35-87A3-15E1991EFD04Q24813432-7B69F9F4-C343-4D52-AA79-573866E18F2AQ24814268-CEB1878D-D3F4-49D9-B1C0-D74D87AD8563Q25256718-A6ECD49A-8853-4B23-8263-F2EA54CC4DD5Q26765518-4253D7C1-3149-4629-9B64-F9A1971116CCQ26998901-6EC20955-17CE-487A-A431-DE76AAC83C32Q27324737-810AEC9D-0705-489D-9816-15FA7D2D5391Q28385894-7E75F5FE-B1F9-493A-9300-388EBA1A1B73Q28386384-B7381F44-5898-4BC4-B67C-A5B620992EF1Q28387831-CE3EDDA7-4DA1-4B88-80FE-846BB1737834Q28388934-61B8AD25-712D-45F5-B1E0-ACEDC7C4A734Q28389752-FCE36E39-24C4-40EB-B9FD-19A3665012A2Q28390395-0C790BED-43C0-4BC2-8564-6962ADA51AB9Q28390782-42458F1A-C767-4F8B-8CBB-C6CA407A2220Q28391764-6C6DF668-CD7A-4EED-9C69-4FFAD2392D90Q28391899-886B7AFB-BF10-45A4-8DAC-D7258372AEB8Q28393907-8E965F51-E84A-4C29-8D69-39EA9A8526EFQ28394428-332020E9-5AEB-4F00-BE7E-8BC644419AE9Q28395938-7394E5B2-7257-4089-8A97-30D77B2B2EC9Q28397616-891635A8-9466-46B0-AF69-D3CACF7AFD50Q28397971-1010C095-6686-403A-AE82-E655FCAA878BQ28595925-55E8AA54-3BC4-415D-89BD-E6866BDC96EEQ28654255-6D9EF962-C2B5-4D9A-8906-A091063DCC28Q28679154-2145CEDD-249B-4E5C-AE50-AF20F48B73B2Q28750445-DEA925C3-6CF2-44B7-BD1F-3C60190B6314Q28752173-723C0D52-4068-4C12-96FE-0EB5A68BCCCFQ30420406-6C676DC2-11DB-49C1-8CF2-E088D4E84484Q30436959-8834C2FF-7D4E-4E7B-9D6E-16EADE20185FQ31117978-8F93CA5A-EC05-48BD-B95A-C755290038F6Q33649020-E4BD1EBC-767E-4B32-9EC0-970353127EB0Q33649496-72B10345-A0B0-4818-A1F5-6FB055F432DDQ33884154-C5D64122-9D41-4E86-80FD-16A5F536CED8Q33964014-57F0026E-8B22-4BA6-BC78-3F2CF1C18521Q33965775-22040CC3-049A-41FF-AD39-2F0D9CE8A23CQ33995641-B20FDE40-4FE1-49B7-BB4E-91838A0A85DBQ34155488-3A410105-719B-4028-8FF4-8753253D41EBQ34185125-B994FF39-55BB-409F-90FD-180032BB708FQ34288589-799EE5E9-ECA4-406F-B00F-28E40482858A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Arsenic toxicity and potential mechanisms of action.
@ast
Arsenic toxicity and potential mechanisms of action.
@en
Arsenic toxicity and potential mechanisms of action.
@nl
type
label
Arsenic toxicity and potential mechanisms of action.
@ast
Arsenic toxicity and potential mechanisms of action.
@en
Arsenic toxicity and potential mechanisms of action.
@nl
prefLabel
Arsenic toxicity and potential mechanisms of action.
@ast
Arsenic toxicity and potential mechanisms of action.
@en
Arsenic toxicity and potential mechanisms of action.
@nl
P1433
P1476
Arsenic toxicity and potential mechanisms of action.
@en
P2093
Michael F Hughes
P356
10.1016/S0378-4274(02)00084-X
P577
2002-07-01T00:00:00Z